These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 8037915

  • 41. The concept of corticosteroid cataractogenic factor revisited.
    Fournier C, Milot JA, Clermont MJ, O'Regan S.
    Can J Ophthalmol; 1990 Dec; 25(7):345-7. PubMed ID: 2090339
    [Abstract] [Full Text] [Related]

  • 42. Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.
    Hill P, Cross NB, Barnett AN, Palmer SC, Webster AC.
    Cochrane Database Syst Rev; 2017 Jan 11; 1(1):CD004759. PubMed ID: 28073178
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Pediatric renal transplantation under tacrolimus-based immunosuppression.
    Shapiro R, Scantlebury VP, Jordan ML, Vivas C, Ellis D, Lombardozzi-Lane S, Gilboa N, Gritsch HA, Irish W, McCauley J, Fung JJ, Hakala TR, Simmons RL, Starzl TE.
    Transplantation; 1999 Jan 27; 67(2):299-303. PubMed ID: 10075598
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation.
    Sarwal MM, Yorgin PD, Alexander S, Millan MT, Belson A, Belanger N, Granucci L, Major C, Costaglio C, Sanchez J, Orlandi P, Salvatierra O.
    Transplantation; 2001 Jul 15; 72(1):13-21. PubMed ID: 11468528
    [Abstract] [Full Text] [Related]

  • 48. Steroid minimization in liver transplant recipients: impact on hepatitis C recurrence and post-transplant diabetes.
    Humar A, Crotteau S, Gruessner A, Kandaswamy R, Gruessner R, Payne W, Lake J.
    Clin Transplant; 2007 Jul 15; 21(4):526-31. PubMed ID: 17645714
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Campath-1H in renal transplantation: The University of Wisconsin experience.
    Knechtle SJ, Fernandez LA, Pirsch JD, Becker BN, Chin LT, Becker YT, Odorico JS, D'alessandro AM, Sollinger HW.
    Surgery; 2004 Oct 15; 136(4):754-60. PubMed ID: 15467659
    [Abstract] [Full Text] [Related]

  • 51. Improved cardiovascular risk factors in pediatric renal transplant recipients on steroid avoidance immunosuppression: A study of the Midwest Pediatric Nephrology Consortium.
    Weaver DJ, Selewski D, Janjua H, Iorember F.
    Pediatr Transplant; 2016 Feb 15; 20(1):59-67. PubMed ID: 26585354
    [Abstract] [Full Text] [Related]

  • 52. Single-center experience in pediatric renal transplantation using thymoglobulin induction and steroid minimization.
    Warejko JK, Hmiel SP.
    Pediatr Transplant; 2014 Dec 15; 18(8):816-21. PubMed ID: 25311592
    [Abstract] [Full Text] [Related]

  • 53. Early steroid withdrawal in solitary pancreas transplantation results in equivalent graft and patient survival compared with maintenance steroid therapy.
    Vessal G, Wiland AM, Philosophe B, Fink JC, Weir MR, Klassen DK.
    Clin Transplant; 2007 Dec 15; 21(4):491-7. PubMed ID: 17645708
    [Abstract] [Full Text] [Related]

  • 54. WOFIE synergizes with calcineurin-inhibitor treatment and early steroid withdrawal in kidney transplantation.
    Dresske B, Zavazava N, Jenisch S, Exner B, Lenz P, El Mokhtari NE, Kremer B, Faendrich F.
    Transplantation; 2003 Apr 27; 75(8):1286-91. PubMed ID: 12717217
    [Abstract] [Full Text] [Related]

  • 55. [Evaluation of efficacy and safety on steroid withdraw at the seventh day after liver transplantation].
    Hu AB, He XS, Wu ZP, Zhu XF, Ma Y, Wang DP, Wang GD, Tai Q, Ju WQ, Wu LW, Huang JF.
    Zhonghua Wai Ke Za Zhi; 2008 Aug 01; 46(15):1126-8. PubMed ID: 19094670
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Ocular complications in renal transplant recipients.
    Berkowitz JS, David DS, Sakai S, Shoji H, Cheigh JS, Riggio RR, Stenzel KH, Rubin AL.
    Am J Med; 1973 Oct 01; 55(3):492-5. PubMed ID: 4582704
    [No Abstract] [Full Text] [Related]

  • 60. Effect of prednisone versus no prednisone as part of maintenance immunosuppression on long-term renal transplant function.
    Gallon LG, Winoto J, Leventhal JR, Parker MA, Kaufman DB.
    Clin J Am Soc Nephrol; 2006 Sep 01; 1(5):1029-38. PubMed ID: 17699323
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.